478 related articles for article (PubMed ID: 17656463)
1. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss.
Esler WP; Rudolph J; Claus TH; Tang W; Barucci N; Brown SE; Bullock W; Daly M; Decarr L; Li Y; Milardo L; Molstad D; Zhu J; Gardell SJ; Livingston JN; Sweet LJ
Endocrinology; 2007 Nov; 148(11):5175-85. PubMed ID: 17656463
[TBL] [Abstract][Full Text] [Related]
2. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.
Rudolph J; Esler WP; O'connor S; Coish PD; Wickens PL; Brands M; Bierer DE; Bloomquist BT; Bondar G; Chen L; Chuang CY; Claus TH; Fathi Z; Fu W; Khire UR; Kristie JA; Liu XG; Lowe DB; McClure AC; Michels M; Ortiz AA; Ramsden PD; Schoenleber RW; Shelekhin TE; Vakalopoulos A; Tang W; Wang L; Yi L; Gardell SJ; Livingston JN; Sweet LJ; Bullock WH
J Med Chem; 2007 Oct; 50(21):5202-16. PubMed ID: 17887659
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.
Mosa R; Huang L; Li H; Grist M; LeRoith D; Chen C
Am J Physiol Regul Integr Comp Physiol; 2018 Jan; 314(1):R71-R83. PubMed ID: 28903914
[TBL] [Abstract][Full Text] [Related]
4. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
Yakabi K; Kurosawa S; Tamai M; Yuzurihara M; Nahata M; Ohno S; Ro S; Kato S; Aoyama T; Sakurada T; Takabayashi H; Hattori T
Regul Pept; 2010 Apr; 161(1-3):97-105. PubMed ID: 20171995
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
[TBL] [Abstract][Full Text] [Related]
6. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats.
Salomé N; Haage D; Perrissoud D; Moulin A; Demange L; Egecioglu E; Fehrentz JA; Martinez J; Dickson SL
Eur J Pharmacol; 2009 Jun; 612(1-3):167-73. PubMed ID: 19356720
[TBL] [Abstract][Full Text] [Related]
7. LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity.
Lu X; Huang L; Huang Z; Feng D; Clark RJ; Chen C
Front Endocrinol (Lausanne); 2021; 12():717544. PubMed ID: 34512549
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin's Orexigenic Effect Is Modulated via a Serotonin 2C Receptor Interaction.
Schellekens H; De Francesco PN; Kandil D; Theeuwes WF; McCarthy T; van Oeffelen WE; Perelló M; Giblin L; Dinan TG; Cryan JF
ACS Chem Neurosci; 2015 Jul; 6(7):1186-97. PubMed ID: 25727097
[TBL] [Abstract][Full Text] [Related]
9. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor.
Zizzari P; Halem H; Taylor J; Dong JZ; Datta R; Culler MD; Epelbaum J; Bluet-Pajot MT
Endocrinology; 2005 Sep; 146(9):3836-42. PubMed ID: 15919752
[TBL] [Abstract][Full Text] [Related]
10. Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor.
Giorgioni G; Del Bello F; Quaglia W; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Piergentili A
J Med Chem; 2022 Feb; 65(4):3098-3118. PubMed ID: 35157454
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.
Asakawa A; Inui A; Kaga T; Katsuura G; Fujimiya M; Fujino MA; Kasuga M
Gut; 2003 Jul; 52(7):947-52. PubMed ID: 12801949
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats.
Landgren S; Simms JA; Hyytiä P; Engel JA; Bartlett SE; Jerlhag E
Addict Biol; 2012 Jan; 17(1):86-94. PubMed ID: 21309944
[TBL] [Abstract][Full Text] [Related]
14. Food restriction, ghrelin, its antagonist and obestatin control expression of ghrelin and its receptor in chicken hypothalamus and ovary.
Sirotkin AV; Pavlova S; Tena-Sempere M; Grossmann R; Jiménez MR; Rodriguez JM; Valenzuela F
Comp Biochem Physiol A Mol Integr Physiol; 2013 Jan; 164(1):141-53. PubMed ID: 22877785
[TBL] [Abstract][Full Text] [Related]
15. A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain.
Halem HA; Taylor JE; Dong JZ; Shen Y; Datta R; Abizaid A; Diano S; Horvath TL; Culler MD
Neuroendocrinology; 2005; 81(5):339-49. PubMed ID: 16210868
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
[TBL] [Abstract][Full Text] [Related]
17. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
Xin Z; Serby MD; Zhao H; Kosogof C; Szczepankiewicz BG; Liu M; Liu B; Hutchins CW; Sarris KA; Hoff ED; Falls HD; Lin CW; Ogiela CA; Collins CA; Brune ME; Bush EN; Droz BA; Fey TA; Knourek-Segel VE; Shapiro R; Jacobson PB; Beno DW; Turner TM; Sham HL; Liu G
J Med Chem; 2006 Jul; 49(15):4459-69. PubMed ID: 16854051
[TBL] [Abstract][Full Text] [Related]
18. Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity.
Wiedemann T; Bielohuby M; Müller TD; Bidlingmaier M; Pellegata NS
Diabetes; 2016 Feb; 65(2):406-20. PubMed ID: 26512025
[TBL] [Abstract][Full Text] [Related]
19. On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist.
Salomé N; Hansson C; Taube M; Gustafsson-Ericson L; Egecioglu E; Karlsson-Lindahl L; Fehrentz JA; Martinez J; Perrissoud D; Dickson SL
J Neuroendocrinol; 2009 Sep; 21(9):777-85. PubMed ID: 19703102
[TBL] [Abstract][Full Text] [Related]
20. Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice.
Holubová M; Nagelová V; Lacinová Z; Haluzík M; Sýkora D; Moulin A; Blayo AL; Fehrentz JA; Martinez J; Stofkova A; Jurčovičová J; Zelezná B; Maletínská L
Mol Cell Endocrinol; 2014 Aug; 393(1-2):120-8. PubMed ID: 24953973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
